Page 34 - Read Online
P. 34

Soren et al. Cancer Drug Resist 2020;3:18-25  I  http://dx.doi.org/10.20517/cdr.2019.106                                                           Page 21








































               Figure 3. The mechanism of action of hTopIB by controlled rotation. The figure shows the different steps of enzyme catalysis during DNA
               relaxation, starting from hTopIB binding to enzyme release. The magnification in the controlled rotation step represents the catalytic
               pentad. The enzyme core domain is in red, the linker is in green, the C-terminal domain is in yellow, and DNA is in blue. This molecular
               picture was produced with UCSF Chimera program [35]

                                                         [31]
               contribution in the process of controlled rotation . The charged residues on the linker domain and nose
                                                                                                       [32]
               cone form an electrostatic interaction with the DNA, allowing a free rotation surrounding the protein .
               The C-terminal domain is an 8-kDa highly conserved domain and contains the catalytically active site
               Tyr723 [Figure 1]. This domain also contains a number of residues responsible for the interactions with
                    [33]
               DNA . Cleavage of the DNA backbone is performed by nucleophilic attack of Tyr723 on the scissile
               phosphate; a phosphodiester link is generated between the tyrosine and the 3’ phosphate, releasing a 5’
                       [34]
               hydroxyl . The C-terminal region has also been shown to bind ATP (adenosine triphosphate) and carry
                                                    [33]
               out splicing factor phosphorylating activity .

               MECHANICS OF ACTION AND ROLE OF THE DOMAINS IN DRUG SENSITIVITY
               The topoisomerization reaction begins with the binding of hTopIB to the duplex DNA. For the binding to
               happen, the enzyme should initially exist in an “open” conformation, which is most likely achieved by a
               hinge-bending motion situated at the edge between core subdomains I and III (residue Pro431) and the
               boundary between helices 8 and 9 (residue Lys452). This region of the protein is sensitive to proteolysis
               when the DNA is not present but becomes resistant upon DNA binding. The binding step occurs through
               the interaction of the charges present on the surface of the enzyme and DNA. This step culminates with
               the protein that completely embraces the DNA as a “clamp” such that the lips of core subdomains I and
               III touch each other. As a result of this event, the active site residues are arranged in position for attacking
               the scissile phosphate, which leads to the cleavage of the strand and formation of the covalent attachment
               between the enzyme and the 3’ end of the DNA. Once the covalent intermediate has been formed, the
               release of superhelical tension can occur through one or more cycles of controlled rotation, which involves
   29   30   31   32   33   34   35   36   37   38   39